GPX4 and gastrointestinal stromal tumor: Moreover, the proportion of FTH1 and GPX4 high expression in imatinib‐resistant GIST samples is greater than that in imatinib‐sensitive samples, confirmed by the quantification of IHC staining (Figure 1G,H).